Search Results 21-30 of 11614 for Dihydroberberine
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...
This study is being done to gather information regarding your health in relation to your composite tissue transplant. We would like to use your medical records ...
Cortes P, Nelson AD, Stancampiano F, Harris D, Tice M, Krishna M, Hodge DO, Bolan CW, Ji B, Gomez V, Bi Y, Stauffer JA. Derivation of the CB2D Score to Predict ...
The purpose of this study is to demonstrate the superiority of SER-109 vs placebo to reduce recurrence of CDI in adults up to 8 weeks after initiation of ...
Helmers RA, Byrne TJ, Wesselius LJ, Leslie KO. Serious Pulmonary Toxicity Secondary to Novel Hepatitis C Antiviral Therapy in a Liver Transplant Recipient. Mayo ...
The primary purpose of this study is to assess short-term morbidity and disease-free survival outcomes for patients with pancreatic adenocarcinoma with ...
Robert C. Huebert, M.D., and Jorge Rakela, M.D., of Mayo Clinic discuss the regenerative properties of the liver to help those with chronic liver disease.
The purose of this study is to determine how well binimetinib and palbociclib work compared to TAS-102 in treating patients with KRAS and NRAS mutation positive ...
The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.